| Literature DB >> 36110530 |
Chenqinyao Li1,2, Changqing Zhang1,2,3, Chengyue Zhu1,2, Jie Zhang4, Qing Xia1,2, Kechun Liu1,2, Yun Zhang1,2.
Abstract
Triptolide is a major compound isolated from the Tripterygium wilfordii Hook that is mainly used for the treatment of autoimmune disorders and inflammatory diseases. Though triptolide-induced hepatotoxicity has been widely reported, the hepatic effects when the patients are in an inflammatory state are not clear. In this study, we used low-dose Lipopolysaccharides (LPS) to disrupt the inflammation homeostasis in the liver of zebrafish and explored the hepatotoxicity of triptolide under an inflammatory state. Compared with the Triptolide group, LPS-Triptolide cotreatment exacerbate the liver injury with a remarkable decrease of liver size and liver-specific fluorescence intensity, accompanied by significant elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities. Liver cell damages were further demonstrated by histological staining and scanning electron microscopy observation. Lipid metabolism was severely impaired as indicated by delayed yolk sac absorption, accumulated triglycerides in the liver, and dysregulation of the related genes, such as ppar-α, cpt-1, mgst, srebf1/2, and fasn. Oxidative stress could be involved in the molecular mechanism as the Nrf2/keap1 antioxidant pathways were down-regulated when the zebrafish in an inflammatory state. Moreover, the expression of autophagy-related genes such as beclin, atg5, map1lc3b, and atg3 was also dysregulated. Finally, apoptosis was significantly induced in responses to LPS-Triptolide co-treatment. We speculate that triptolide could exacerbate the immune response and impair lipid metabolism, resulting in enhanced sensitivity of the zebrafish liver to triptolide-induced toxic effects through disruption of the antioxidant system and induction of apoptosis.Entities:
Keywords: hepatotoxicity; inflammation; lipid metabolism; triptolide; zebrafish
Year: 2022 PMID: 36110530 PMCID: PMC9468416 DOI: 10.3389/fphar.2022.949312
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
The gene Primers for Quantitative Real-time PCR.
| Primer | Sequence | Length (nucleotide) | |
|---|---|---|---|
|
| Forward | ATACAGCCAGGTCCTTGCTAATG | 23 |
| Reverse | GTGACGGAGACCACGGTGAG | 20 | |
|
| Forward | TGAAGACACTCAGAGACGAGCAGTT | 25 |
| Reverse | AGGTTTGAGGAGAGGAGTGCTGAT | 24 | |
|
| Forward | TGGACTTCGCAGCACAAAATG | 21 |
| Reverse | CACTTCACGCTCTTGGATGA | 20 | |
|
| Forward | GAACAACCCAGCAAACTC | 18 |
| Reverse | CATCACCAGCGGTAAAGG | 18 | |
|
| Forward | CTGCGGGACATCTCTCAGTC | 20 |
| Reverse | ACCGTAAACACCTGACGACG | 20 | |
|
| Forward | ATGAGGAGCACCAAAGAATG | 20 |
| Reverse | TGGGAAAAGCGTAAAGAAAG | 20 | |
|
| Forward | GATATGTGGCGCTAACCGGA | 20 |
| Reverse | ATGCTGAATCCCACCCACAG | 20 | |
|
| Forward | CATCCACATGGCTCTGAGTG | 20 |
| Reverse | CTCATCCACAAAGAAGCGGT | 20 | |
|
| Forward | CACTCACACAAGACACACAG | 20 |
| Reverse | ACCTGGTTCTGGATGAATCG | 20 | |
|
| Forward | GCACCGGTACTAAGGTTGGA | 20 |
| Reverse | ACACAACCGACCATCTGTCA | 20 | |
|
| Forward | ATGTCTAAAATGCAGCCAAGCC | 22 |
| Reverse | CGGTAGCTGAAGTCGAACAC | 20 | |
|
| Forward | CTGGGTGGTGTGTTTGAAGAA | 21 |
| Reverse | GCTGTGGTAATGCCGTAGG | 19 | |
|
| Forward | ATACCAACCAGACACCAACAC | 21 |
| Reverse | GGTTTGTCCATCATAGCCTCC | 21 | |
|
| Forward | CGCAGACTGAAAGTGACAAGC | 21 |
| Reverse | TCTGGCACTCGTTCTCAGTG | 20 | |
|
| Forward | AGAGAGGCAGAACCCTACTATC | 22 |
| Reverse | CCTCGTGTTCAAACCACATTTC | 22 | |
|
| Forward | CTCCAACCAGGCTTTCTTCCT | 21 |
| Reverse | CCTCAGAAATGGCAGTGGACA | 21 | |
|
| Forward | GGAAGATGCCATTCTACAGACAAG | 24 |
| Reverse | AGGTGGAGGGAGATTAGGGTG | 21 | |
|
| Forward | GAGACCAACCAGGCCAAGAC | 20 |
| Reverse | TCTCGTGCCTTATGCGTTTAGAT | 23 | |
|
| Forward | AAGACCTGATTCTGCGACTG | 20 |
| Reverse | TAGGCTGAGACACCTTTACG | 20 | |
|
| Forward | TCAGTCACGGCGATGAGGG | 19 |
| Reverse | CCTCGACAAGCCTGAATAAAGAAC | 24 |
FIGURE 1The effect of triptolide on the inflammatory cells and liver morphology after the stimulation of LPS. (A) Morphological changes in the liver and distribution of inflammatory cells in zebrafish. Green fluorescence represents the liver; red fluorescence represents inflammatory cells. (B) Density of inflammatory cells in the liver. (C) Liver fluorescence area. (D) Liver fluorescence intensity. (E) Liver 3D morphology. (F) Liver 3D volume. The larvae are photographed with their heads to the left and their eyes overlapping in a side-lying position. The white arrow points to a 3D stereoscopic front view of the liver in direct view. The white dashed arrow is a 3D stereoscopic elevation view of the liver viewed from the abdomen. **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. the blank control group. #p < 0.05, ##p < 0.01, ####p < 0.0001 vs. the Triptolide (Trip) group.
FIGURE 2Biochemical analysis of the effect of triptolide. (A) ALT activity in zebrafish. (B) AST activity in zebrafish. ***p < 0.001, ****p < 0.0001 vs. the blank control group. #p < 0.05, ####p < 0.0001 vs. the Triptolide (Trip) group.
FIGURE 3The effect of triptolide on the liver tissue pathology and hepatocyte ultrastructure of zebrafish in an inflammatory state. (A) Hepatic pathological section staining, white dotted circles represent hepatocyte hypertrophy, white dotted arrows represent lipid droplets, and white arrows represent vacuolization. Magnification ×40. (B) Electron microscopy of liver ultrastructure, nuclei (N), mitochondria (M), rough endoplasmic reticulum (RER), microvilli (Mv), lysosomes (Ly), autolysosomes (ASS), and lipid droplets (LDs).
FIGURE 4The effect of triptolide on lipid metabolism in zebrafish in an inflammatory state. (A) Changes in yolk sac of zebrafish, yolk sac were outlined with white dotted lines. (B) Zebrafish yolk sac area. (C) Oil red O staining, liver was outlined with white dotted lines. (D) Oil red O staining quantification. *p < 0.05, ****p < 0.0001 vs. the blank control group. ###p < 0.001, ####p < 0.0001 vs. the Triptolide (Trip) group.
FIGURE 5The effect of triptolide on gene expression in zebrafish in an inflammatory state. (A) Inflammation-related genes. (B) Oxidative stress-related genes. (C) Lipid metabolism-related genes. (D) Autophagy-related genes. (E) Apoptosis-related genes. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. the blank control group. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs. the Triptolide (Trip) group.
FIGURE 6Correlation analysis of inflammation-related factors with liver toxicity indicators in zebrafish. (A) Inflammatory cells density. (B) mRNA expression levels of il-6. (C) mRNA expression levels of il-1b. (D) mRNA expression levels of tnf-α. Liver toxicity indicators: liver fluorescence area, ALT and AST activity values, and optical density of Oil red O staining (Integrated Optical Density).
FIGURE 7The schematic diagram of the enhanced hepatotoxicity of triptolide in zebrafish under inflammatory state regarding inflammation, oxidative stress, lipid metabolism, autophagy and apoptosis.